• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国类风湿关节炎的患病率和发病率。

Prevalence and incidence of rheumatoid arthritis in South Korea.

机构信息

Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 133-792, South Korea.

出版信息

Rheumatol Int. 2013 Jun;33(6):1525-32. doi: 10.1007/s00296-012-2590-2. Epub 2012 Dec 20.

DOI:10.1007/s00296-012-2590-2
PMID:23255140
Abstract

Several studies of rheumatoid arthritis (RA) incidence and prevalence indicate that occurrence of the disease varies significantly among different populations. We aimed to estimate the prevalence and incidence of RA in South Korea. We used Korean National Health Insurance (NHI) claims data to estimate the prevalence of RA in 2007-2009 and the incidence of RA in 2008. On the basis of our previous validation study, the presence of RA was defined by the diagnostic code for RA with biologic or non-biologic disease-modifying anti-rheumatic drugs in the same claim in each year. To estimate the incidence of RA, we identified cases of RA in 2008 and set the 12-month period prior to 2008 as a disease-free period. Among the incident case of 2008, only patients who continued treatment in 2009 were defined as true incident case of RA in 2008. The corresponding prevalence estimates were 0.26 % (95 % CI 0.25-0.27) in 2006, 0.27 % (95 % CI 0.26-0.28) in 2007, and 0.27 % (95 % CI 0.26-0.28) in 2008. The incidence of RA in 2008 was estimated at 42/100,000 (95 % CI 29.3-54.7) in the general population of South Korea. Data gathered nationwide through the NHI yielded estimates of RA prevalence and incidence in South Korea. This study is the first report of nationwide prevalence and incidence of South Korea and those are comparable to values for other countries in Asia.

摘要

几项关于类风湿关节炎(RA)发病率和患病率的研究表明,该疾病在不同人群中的发生情况存在显著差异。我们旨在评估韩国 RA 的患病率和发病率。我们使用韩国国家健康保险(NHI)理赔数据来估计 2007-2009 年 RA 的患病率和 2008 年 RA 的发病率。根据我们之前的验证研究,RA 的存在是通过每年同一份理赔中 RA 的诊断代码以及生物或非生物的疾病修正抗风湿药物来定义的。为了估计 RA 的发病率,我们确定了 2008 年的 RA 病例,并将 2008 年前的 12 个月定为无病期。在 2008 年的新发病例中,只有在 2009 年继续治疗的患者才被定义为 2008 年真正的 RA 新发病例。相应的患病率估计值为:2006 年为 0.26%(95%可信区间 0.25-0.27),2007 年为 0.27%(95%可信区间 0.26-0.28),2008 年为 0.27%(95%可信区间 0.26-0.28)。韩国普通人群 2008 年 RA 的发病率估计为 42/100,000(95%可信区间 29.3-54.7)。通过 NHI 收集的全国性数据得出了韩国 RA 的患病率和发病率的估计值。这项研究是韩国全国 RA 患病率和发病率的首次报告,与亚洲其他国家的值相当。

相似文献

1
Prevalence and incidence of rheumatoid arthritis in South Korea.韩国类风湿关节炎的患病率和发病率。
Rheumatol Int. 2013 Jun;33(6):1525-32. doi: 10.1007/s00296-012-2590-2. Epub 2012 Dec 20.
2
Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization.韩国类风湿关节炎的患病率和发病率更新及医疗保健和药物利用情况分析。
Rheumatol Int. 2018 Apr;38(4):649-656. doi: 10.1007/s00296-017-3925-9. Epub 2018 Jan 4.
3
Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database.开发一种从韩国国民健康保险索赔数据库中识别类风湿性关节炎的算法。
Rheumatol Int. 2013 Dec;33(12):2985-92. doi: 10.1007/s00296-013-2833-x. Epub 2013 Aug 6.
4
Association of acute myocardial infarction with seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.韩国急性心肌梗死与血清学阳性类风湿关节炎的关联:一项全国性纵向队列研究。
J Clin Neurosci. 2020 Aug;78:97-101. doi: 10.1016/j.jocn.2020.06.002. Epub 2020 Jul 1.
5
Rheumatoid Arthritis and Risk of Depression in South Korea.类风湿关节炎与韩国的抑郁风险。
JAMA Netw Open. 2024 Mar 4;7(3):e241139. doi: 10.1001/jamanetworkopen.2024.1139.
6
Mortality, disability, and healthcare expenditure of patients with seropositive rheumatoid arthritis in Korea: A nationwide population-based study.韩国血清阳性类风湿关节炎患者的死亡率、残疾率和医疗支出:一项全国性基于人群的研究。
PLoS One. 2019 Jan 8;14(1):e0210471. doi: 10.1371/journal.pone.0210471. eCollection 2019.
7
Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data.抗 TNF 治疗后类风湿关节炎患者的恶性肿瘤风险:来自韩国国家健康保险索赔数据的结果。
Korean J Intern Med. 2019 May;34(3):669-677. doi: 10.3904/kjim.2016.374. Epub 2017 Nov 29.
8
Increased risk of opportunistic infection in early rheumatoid arthritis.早期类风湿关节炎患者发生机会性感染的风险增加。
Int J Rheum Dis. 2019 Jul;22(7):1239-1246. doi: 10.1111/1756-185X.13585. Epub 2019 May 14.
9
Relationship of rheumatoid arthritis and coronary artery disease in the Korean population: a nationwide cross-sectional study.类风湿关节炎与冠状动脉疾病在韩国人群中的关系:一项全国性横断面研究。
Adv Rheumatol. 2019 Aug 27;59(1):40. doi: 10.1186/s42358-019-0084-6.
10
Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry.生物性抗风湿药物与类风湿关节炎患者新发高血压之间的关联:来自全国性前瞻性KOBIO注册研究的结果
Medicine (Baltimore). 2020 Feb;99(9):e19415. doi: 10.1097/MD.0000000000019415.

引用本文的文献

1
Incidence and prevalence of rheumatoid arthritis in Thailand based on National administrative health data and a comprehensive literature review.基于国家行政卫生数据和全面文献综述的泰国类风湿关节炎发病率和患病率
Sci Rep. 2025 Jul 1;15(1):20665. doi: 10.1038/s41598-025-07376-w.
2
Application of disease activity index in rheumatoid arthritis management in Korea.疾病活动指数在韩国类风湿关节炎管理中的应用。
J Rheum Dis. 2024 Oct 1;31(4):193-199. doi: 10.4078/jrd.2024.0077. Epub 2024 Aug 2.
3
DA-9601 has protective effects comparable to those of proton pump inhibitor and rebamipide against nonsteroidal anti-inflammatory drugs-induced upper and lower gastrointestinal bleeding in patients with rheumatoid arthritis: A nationwide study using Korean Health Insurance Review and Assessment Service database.

本文引用的文献

1
Korean Observational Study Network for Arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea.韩国关节炎观察研究网络(KORONA):在韩国建立一个前瞻性的多中心类风湿关节炎队列。
Semin Arthritis Rheum. 2012 Jun;41(6):745-51. doi: 10.1016/j.semarthrit.2011.09.007. Epub 2011 Dec 9.
2
Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden.瑞典全国范围内类风湿关节炎的流行情况及疾病修饰药物的渗透情况。
Ann Rheum Dis. 2011 Apr;70(4):624-9. doi: 10.1136/ard.2010.133371. Epub 2010 Dec 13.
3
Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics.
DA-9601 对类风湿关节炎患者非甾体抗炎药相关上、下消化道出血的预防作用与质子泵抑制剂和瑞巴派特相当:一项使用韩国健康保险审查和评估服务数据库的全国性研究。
Medicine (Baltimore). 2024 Jul 5;103(27):e38801. doi: 10.1097/MD.0000000000038801.
4
National trends in rheumatoid arthritis and osteoarthritis prevalence in South Korea, 1998-2021.韩国类风湿关节炎和骨关节炎患病率的全国趋势,1998-2021 年。
Sci Rep. 2023 Nov 9;13(1):19528. doi: 10.1038/s41598-023-46279-6.
5
Treatment Sequence After Initiating Biologic Therapy for Patients With Rheumatoid Arthritis in Korea: A Nationwide Retrospective Cohort Study.韩国类风湿关节炎患者启动生物治疗后的治疗顺序:一项全国性回顾性队列研究。
J Rheum Dis. 2023 Jan 1;30(1):26-35. doi: 10.4078/jrd.22.0024. Epub 2022 Aug 30.
6
Epidemiology of Rheumatoid Arthritis in Korea.韩国类风湿关节炎的流行病学
J Rheum Dis. 2021 Apr 1;28(2):60-67. doi: 10.4078/jrd.2021.28.2.60.
7
Joint Replacement Surgery in Patients with Rheumatoid Arthritis in South Korea: Analysis of a Large National Database.韩国类风湿关节炎患者的关节置换手术:大型国家数据库分析。
Clin Orthop Surg. 2023 Jun;15(3):395-401. doi: 10.4055/cios21274. Epub 2022 Nov 24.
8
The prevalence of rheumatoid arthritis in Western Australia.西澳大利亚州类风湿关节炎的患病率。
BMC Rheumatol. 2022 Dec 31;6(1):93. doi: 10.1186/s41927-022-00324-5.
9
Potential Cancer Risk in Patients with Rheumatoid Arthritis: A Longitudinal Korean Population-Based Analysis.类风湿关节炎患者的潜在癌症风险:一项基于韩国人群的纵向分析。
J Pers Med. 2022 Jun 13;12(6):965. doi: 10.3390/jpm12060965.
10
Silencing CoREST inhibits the viability and migration of fibroblast-like synoviocytes in TNF-α-induced rheumatoid arthritis.沉默CoREST可抑制肿瘤坏死因子-α诱导的类风湿性关节炎中滑膜成纤维样细胞的活力和迁移。
Exp Ther Med. 2022 Feb;23(2):148. doi: 10.3892/etm.2021.11071. Epub 2021 Dec 15.
2008 年瑞典南部类风湿关节炎的流行率和发病率及其与处方生物制剂的关系。
Rheumatology (Oxford). 2010 Aug;49(8):1563-9. doi: 10.1093/rheumatology/keq127. Epub 2010 May 5.
4
Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review.基于1987年美国风湿病学会标准的类风湿关节炎发病率和患病率:一项系统评价
Semin Arthritis Rheum. 2006 Dec;36(3):182-8. doi: 10.1016/j.semarthrit.2006.08.006. Epub 2006 Oct 11.
5
Do patients with older-onset rheumatoid arthritis receive less aggressive treatment?老年发病的类风湿性关节炎患者接受的治疗是否不够积极?
Ann Rheum Dis. 2006 Sep;65(9):1226-9. doi: 10.1136/ard.2005.051144. Epub 2006 Jan 13.
6
Epidemiology of adult rheumatoid arthritis.成人类风湿关节炎的流行病学
Autoimmun Rev. 2005 Mar;4(3):130-6. doi: 10.1016/j.autrev.2004.09.002.
7
The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey.土耳其伊兹密尔城市人口中类风湿关节炎的患病率。
Clin Exp Rheumatol. 2004 Jul-Aug;22(4):416-20.
8
Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach.巴西风湿性疾病的患病率:一项采用社区导向基层医疗(COPCORD)方法的研究。
J Rheumatol. 2004 Mar;31(3):594-7.
9
Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study.中国上海风湿性症状、类风湿关节炎、强直性脊柱炎及痛风的患病率:一项社区导向的基层医疗研究(COPCORD研究)
J Rheumatol. 2003 Oct;30(10):2245-51.
10
Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study.希腊风湿性疾病的患病率:一项基于人群的横断面流行病学研究。ESORDIG研究。
J Rheumatol. 2003 Jul;30(7):1589-601.